New kid on the block: Roger Perl­mut­ter's biotech signs on as an­chor ten­ant to new Bay Area cam­pus

Hav­ing left be­hind a stel­lar lega­cy in Mer­ck’s head­quar­ters in Ke­nil­worth, NJ, Roger Perl­mut­ter’s next chap­ter of drug R&D will be writ­ten in the San Fran­cis­co Bay Area.

Eikon Ther­a­peu­tics, the am­bi­tious biotech start­up helmed by Perl­mut­ter, has signed a long-term lease to set up its new cor­po­rate head­quar­ters in a new life sci­ences cam­pus be­ing de­vel­oped by Alexan­dria Re­al Es­tate Eq­ui­ties in Mill­brae, CA. As the an­chor ten­ant, Eikon will com­mand about 285,000 square feet — enough to ac­com­mo­date up to 750 em­ploy­ees.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER